Fredun Pharmaceuticals submitted a compliance certificate from its Registrar and Share Transfer Agent for the past quarter. This certificate confirms that all physical shares received for dematerialisation were duly processed, accepted or rejected, and subsequently listed on the stock exchanges. The company ensures that security certificates received were properly cancelled after verification, and electronic records were updated in a timely manner. This process is crucial for maintaining accurate shareholder records and facilitating seamless share transactions for investors.